Stock listing
Aquis:MOBS Moberg Pharma AB Share Price
UK listing (Aquis) of Moberg Pharma AB · home listing Stockholm:MOB
Follow Moberg Pharma AB into a list and get an email when it puts out news.
Home listing price · OMXSTO:MOB
11.02 SEK +0.08 (+0.7%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:MOB
- Day range
- 10.84 – 11.02 SEKOct 30, 2026
- Volume
- 14,216 sharesOct 30, 2026
- Market cap
- 519.9M SEKAt the close on Oct 30, 2026 · price × 47.18M shares outstanding
- 52-week range
- 7.53 – 14.12 SEKLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- 739,506 SEKMedian day 45,708 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:MOB · Home | 11.02 SEK | +0.08 (+0.7%) | 14,216 | 10.94 | 11.02 | 10.84 | 10.94 | Close on Oct 30, 2026 |
| OTC:MBGPF | $1.00 USD | -0.08 (-7.4%) | — | $1.00 | $1.00 | $1.00 | $1.08 | Close on Oct 27, 2026 |
| Frankfurt:MB8 | €0.905 EUR | -0.041 (-4.3%) | — | €0.945 | €0.945 | €0.905 | €0.946 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · OMXSTO:MOB · SEK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 11.02 | +0.08 | +0.7% | 10.94 | 11.02 | 10.84 | 14,216 | |
| 10.94 | -0.08 | -0.7% | 11.00 | 11.04 | 10.80 | 24,864 | |
| 11.02 | +0.12 | +1.1% | 10.80 | 11.02 | 10.66 | 12,148 | |
| 10.90 | -0.18 | -1.6% | 10.94 | 11.14 | 10.74 | 118,565 | |
| 11.08 | +0.08 | +0.7% | 10.98 | 11.12 | 10.80 | 47,636 | |
| 11.00 | -0.10 | -0.9% | 11.00 | 11.08 | 10.76 | 45,058 | |
| 11.10 | 0.00 | 0.0% | 11.00 | 11.14 | 10.94 | 87,009 | |
| 11.10 | -0.02 | -0.2% | 11.06 | 11.10 | 10.94 | 8,240 | |
| 11.12 | +0.02 | +0.2% | 11.12 | 11.12 | 10.92 | 119,340 | |
| 11.10 | -0.14 | -1.2% | 10.98 | 11.20 | 10.90 | 33,994 | |
| 11.24 | -0.10 | -0.9% | 11.14 | 11.40 | 11.08 | 46,847 | |
| 11.34 | 0.00 | 0.0% | 11.34 | 11.34 | 11.00 | 55,517 | |
| 11.34 | +0.04 | +0.4% | 11.18 | 11.40 | 11.18 | 125,394 | |
| 11.30 | -0.20 | -1.7% | 11.40 | 11.44 | 11.22 | 21,238 | |
| 11.50 | +0.20 | +1.8% | 11.64 | 11.64 | 11.18 | 64,884 | |
| 11.30 | -0.18 | -1.6% | 11.18 | 11.46 | 11.18 | 18,515 | |
| 11.48 | +0.34 | +3.1% | 11.14 | 11.48 | 11.00 | 25,600 | |
| 11.14 | -0.08 | -0.7% | 11.04 | 11.14 | 10.86 | 16,314 | |
| 11.22 | +0.16 | +1.4% | 11.04 | 11.24 | 10.94 | 17,578 | |
| 11.06 | -0.08 | -0.7% | 11.30 | 11.62 | 11.04 | 227,970 | |
| 11.14 | +0.14 | +1.3% | 10.98 | 11.14 | 10.82 | 20,533 | |
| 11.00 | -0.30 | -2.7% | 11.20 | 11.22 | 10.96 | 97,984 | |
| 11.30 | +0.10 | +0.9% | 11.00 | 11.32 | 11.00 | 18,260 | |
| 11.20 | +0.16 | +1.4% | 10.94 | 11.22 | 10.78 | 23,496 | |
| 11.04 | -0.22 | -2.0% | 11.42 | 11.52 | 10.96 | 73,568 | |
| 11.26 | -0.04 | -0.4% | 11.44 | 11.70 | 11.20 | 99,012 | |
| 11.30 | +0.40 | +3.7% | 10.78 | 11.46 | 10.68 | 160,079 | |
| 10.90 | +0.20 | +1.9% | 10.64 | 10.90 | 10.50 | 47,079 | |
| 10.70 | -0.30 | -2.7% | 10.86 | 10.94 | 10.60 | 91,051 | |
| 11.00 | +0.16 | +1.5% | 10.86 | 11.00 | 10.84 | 25,859 | |
| 10.84 | +0.24 | +2.3% | 10.86 | 11.00 | 10.84 | 36,548 | |
| 10.60 | -0.24 | -2.2% | 10.76 | 10.76 | 10.58 | 18,763 | |
| 10.84 | -0.16 | -1.5% | 11.02 | 11.08 | 10.70 | 57,184 | |
| 11.00 | -0.10 | -0.9% | 11.04 | 11.24 | 10.84 | 25,648 | |
| 11.10 | -0.24 | -2.1% | 11.24 | 11.34 | 11.06 | 34,071 | |
| 11.34 | +0.40 | +3.7% | 10.74 | 11.46 | 10.66 | 65,112 | |
| 10.94 | -0.22 | -2.0% | 11.04 | 11.24 | 10.90 | 29,899 | |
| 11.16 | +0.10 | +0.9% | 11.00 | 11.20 | 10.82 | 55,355 | |
| 11.06 | +0.42 | +3.9% | 10.90 | 11.06 | 10.66 | 57,243 | |
| 10.64 | -0.72 | -6.3% | 11.38 | 11.38 | 10.64 | 55,159 | |
| 11.36 | +0.24 | +2.2% | 11.12 | 11.56 | 11.12 | 56,774 | |
| 11.12 | -0.34 | -3.0% | 11.20 | 11.70 | 11.06 | 25,416 | |
| 11.46 | +0.20 | +1.8% | 11.24 | 11.46 | 10.80 | 56,195 | |
| 11.26 | +0.12 | +1.1% | 11.16 | 11.28 | 11.16 | 16,787 | |
| 11.14 | +0.22 | +2.0% | 10.90 | 11.16 | 10.50 | 45,708 | |
| 10.92 | +0.32 | +3.0% | 10.56 | 10.92 | 10.54 | 32,676 | |
| 10.60 | -0.18 | -1.7% | 10.34 | 10.78 | 10.34 | 41,764 | |
| 10.78 | +0.08 | +0.7% | 10.60 | 10.80 | 10.58 | 29,387 | |
| 10.70 | +0.58 | +5.7% | 10.30 | 10.80 | 10.30 | 20,006 | |
| 10.12 | -0.50 | -4.7% | 10.88 | 10.88 | 9.91 | 85,401 | |
| 10.62 | -0.70 | -6.2% | 11.30 | 11.40 | 10.62 | 94,332 | |
| 11.32 | +0.18 | +1.6% | 11.28 | 11.46 | 11.28 | 42,784 | |
| 11.14 | -0.26 | -2.3% | 11.40 | 11.40 | 11.10 | 50,617 | |
| 11.40 | -0.38 | -3.2% | 11.86 | 11.90 | 11.22 | 333,776 | |
| 11.78 | +0.70 | +6.3% | 11.36 | 11.92 | 11.36 | 126,830 | |
| 11.08 | +0.14 | +1.3% | 11.20 | 11.38 | 10.96 | 67,289 | |
| 10.94 | -0.46 | -4.0% | 11.68 | 12.00 | 10.62 | 545,672 | |
| 11.40 | +0.24 | +2.2% | 11.18 | 11.48 | 10.90 | 111,204 | |
| 11.16 | +0.88 | +8.6% | 10.42 | 11.50 | 10.42 | 164,330 | |
| 10.28 | +0.29 | +2.9% | 10.30 | 10.30 | 9.85 | 65,973 | |
| 9.99 | +0.48 | +5.0% | 9.66 | 10.12 | 9.50 | 82,628 | |
| 9.51 | +0.01 | +0.1% | 9.69 | 9.72 | 9.50 | 41,414 | |
| 9.50 | -0.06 | -0.6% | 9.50 | 9.68 | 9.40 | 15,676 | |
| 9.56 | -0.14 | -1.4% | 9.69 | 9.70 | 9.35 | 28,433 | |
| 9.70 | +0.25 | +2.6% | 9.44 | 9.75 | 9.25 | 39,066 | |
| 9.45 | -0.03 | -0.3% | 9.48 | 9.68 | 9.40 | 24,186 | |
| 9.48 | -0.29 | -3.0% | 9.77 | 9.78 | 9.45 | 33,838 |
- Ticker
- Aquis:MOBS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Aquis
- Currency
- SEK
What changed lately
Latest news release · Oct 5, 2026
New analyses on terbinafine susceptibility and MOB-015 published in Journal of Fungi
Latest deck · Sep 23, 2026
Redeye Investor Forum, Stockholm 2026
Conference · 17 slides
Calls
Replays
Moberg Pharma (Stockholm:MOB) Q4 2024 Earnings Call
Tue, Feb 11, 2025 · 9:00 AM ET
Watch TranscriptMoberg Pharma (Stockholm:MOB) Q3 2024 Earnings Call
Tue, Nov 12, 2024 · 9:30 AM ET
Watch TranscriptMoberg Pharma (Stockholm:MOB) Q2 2024 Earnings Call
Tue, Aug 13, 2024 · 5:30 AM ET
Watch Transcript
Latest news
New analyses on terbinafine susceptibility and MOB-015 published in Journal of Fungi
Oct 5, 2026
Closed 11.06 (-0.7%) on Oct 5, 2026
Moberg Pharma's Terclara[®](MOB-015) launched in Israel
Sep 23, 2026
Closed 10.90 (+1.9%) on Sep 23, 2026
Moberg Pharma strengthens organization ahead of European launch
Aug 11, 2026
Closed 11.16 (+8.6%) on Aug 11, 2026
New number of shares and votes in Moberg Pharma AB (publ)
Jun 30, 2026
Closed 9.38 (-1.1%) on Jun 30, 2026
Moberg Pharma reports progress on commercial launch preparations
Jun 15, 2026
Closed 9.95 (-1.5%) on Jun 15, 2026
Notice of Annual General Meeting in Moberg Pharma AB (publ)
Apr 17, 2026
Closed 10.54 (+2.7%) on Apr 17, 2026
Moberg Pharma and Karo Healthcare enter into an exclusive license agreement for MOB-015/Terclara in Europe, expanding access and growth potential
Nov 5, 2025
Closed 9.90 (+27.1%) on Nov 5, 2025
Karo Healthcare enters an exclusive license agreement with Moberg Pharma for MOB-015 in Europe
Nov 5, 2025
Closed 9.90 (+27.1%) on Nov 5, 2025
Decks
Redeye Investor Forum, Stockholm 2026
Conference · 17 slides · Sep 23, 2026
Investor Presentation (August 2026)
Investor deck · 19 slides · Aug 13, 2026
Redeye Healthcare Day 2026
Conference · 17 slides · Apr 14, 2026
Stora Aktiedagarna, Stockholm (March 2026)
Conference · 17 slides · Mar 10, 2026
Moberg Pharma AB on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 8 in the last 12 months · 8 in all · newest Oct 5, 2026 · oldest 2025
- Calls
- 7 calls with a replay · 7 with a transcript · latest Feb 11, 2025
- Decks
- 19 decks · latest Sep 23, 2026
Where Moberg Pharma AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:MOB · Home listing | Stockholm | Sweden | SEK |
| gettex:MB8 | gettex | Germany | EUR |
| Aquis:MOBS | Aquis | United Kingdom | SEK |
| OTC:MBGPF | OTC | United States | USD |
| LS Exchange:A3EGXK | LS Exchange | Germany | EUR |
| Lang & Schwarz:A3EGXK | Lang & Schwarz | Germany | EUR |
| Aquis:MOBS · This page | Aquis | United Kingdom | SEK |
| Dusseldorf:MB8 | Dusseldorf | Germany | EUR |
| Frankfurt:MB8 | Frankfurt | Germany | EUR |
| Munich:MB8 | Munich | Germany | EUR |
| Stuttgart:MB8 | Stuttgart | Germany | EUR |
| Tradegate:MB8 | Tradegate | Germany | EUR |
| Turquoise:MOBS | Turquoise | United Kingdom | SEK |
Log in to ask 6ix AI your own questions about Moberg Pharma AB.